CPIX: Cumberland Pharmaceuticals Inc. Stock

by  •  • Comments Off on CPIX: Cumberland Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.81
Enterprise Value ($M) 15.13
Book Value ($M) 24.47
Book Value / Share 1.75
Price / Book 0.69
NCAV ($M) -17.04
NCAV / Share -1.21
Price / NCAV -0.99

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.12
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 0.99
Current Ratio 1.13

Balance Sheet (mrq) ($M)
Current Assets 35.24
Assets 76.75
Liabilities 52.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-09 13G Cumberland Pharmaceuticals Inc 40.14 -1.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-13 10-K ____________________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 22,438 118,768 18.89
2024-11-14 8,769 27,232 32.20
2024-11-13 15,556 52,066 29.88
2024-11-12 13,805 45,704 30.21

(click for more detail)

Similar Companies
CGON – CG Oncology, Inc. COGT – Cogent Biosciences, Inc.
COLL – Collegium Pharmaceutical, Inc. CRBU – Caribou Biosciences, Inc.
CRGX – CARGO Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io